US2019262132A1PendingUtilityA1
Biological tissue for surgical implantation
Est. expiryOct 27, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61L 27/507A61L 2430/40A61F 2/2415A61L 27/3687A61L 27/3604A01N 1/0215A01N 1/124
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating a biological tissue that enables dry storage of said tissue is disclosed. In one embodiment, the method comprises contacting the biological tissue with a non-aqueous treatment solution comprising a polyhydric alcohol and a C 1 -C 3 alcohol and removing a portion of the treatment solution from the solution-treated biological tissue. Also disclosed is biological tissue prepared using the above process and prosthetic devices made with such tissue.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a fixed pericardial tissue, the method comprising:
placing the fixed pericardial tissue in an immersion bath comprising a treatment solution comprising 70% to 95% by volume of one or more polyhydric alcohols and 5% to 30% by volume of an alcohol, wherein the one or more polyhydric alcohols are selected from the group consisting of: glycerol, ethylene glycol, polyethylene glycol, propylene glycol, and butylene glycol; and exposing the fixed pericardial tissue to ambient air or an inert environment to substantially dry the fixed pericardial tissue.
2 . The method of claim 1 , wherein the treatment solution comprises two or more polyhydric alcohols.
3 . The method of claim 2 , wherein the treatment solution comprises glycerol and polypropylene glycol.
4 . The method of claim 1 , wherein the alcohol is one or more of a C 1 -C 3 alcohol.
5 . The method of claim 4 , wherein the one or more C 1 -C 3 alcohols are selected from the group consisting of: methanol, ethanol, isopropanol, and n-propanol.
6 . The method of claim 5 , wherein the one or more C 1 -C 3 alcohols is ethanol.
7 . The method of claim 1 , further comprising placing the fixed pericardial tissue in a second immersion bath before the exposing;
wherein the second immersion bath comprises a second treatment solution comprising 70% to 95% by volume of one or more polyhydric alcohols and 5% to 30% by volume of an alcohol; and wherein the one or more polyhydric alcohols are selected from the group consisting of: glycerol, ethylene glycol, polyethylene glycol, propylene glycol, and butylene glycol.
8 . The method of claim 7 , wherein the treatment solution and the second treatment solution are the same.
9 . The method of claim 7 , wherein the treatment solution and the second treatment solution are different.
10 . The method of claim 1 , wherein the exposing is performed in a clean room or in a laminar flow bench.
11 . The method of claim 10 , wherein the exposing is performed at a temperature of about 15° C. to about 25° C. and at a relative humidity of less than about 50%.
12 . The method of claim 1 , wherein:
the exposing is performed in an inert environment; and the inert environment is under nitrogen.
13 . The method of claim 1 , further comprising packaging the fixed pericardial tissue in a container or package essentially free of liquid to provide a packaged fixed pericardial tissue.
14 . The method of claim 13 , further comprising sterilizing the packaged fixed pericardial tissue by exposure to ionizing radiation or sterilizing gas.
15 . The method of claim 14 , wherein:
the sterilizing is performed with sterilizing gas; and the sterilizing gas is ethylene oxide.
16 . The method of claim 15 , wherein the sterilizing comprises exposing the packaged fixed pericardial tissue to 10% ethylene oxide and 90% hydrochlorofluorocarbon at a chamber pressure of 8 to 10 psig at a temperature of about 38° C. for about 24 hours or at a temperature of 54° C. to 57° C. for about 130 minutes.Join the waitlist — get patent alerts
Track US2019262132A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.